Back to search

Article

Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities

2025-06-20

Abstract excerpt

<h4>SUMMARY</h4> The von Hippel-Lindau tumor suppressor (VHL) is a component of a ubiquitin ligase complex that normally controls cellular responses to hypoxia. Endogenous VHL is also utilized by proteolysis-targeting chimera (PROTAC) protein degraders, a promising class of anti-cancer agents. VHL is broadly essential for cell proliferation, yet it is a key tumor suppressor in renal cell carcinoma. To understand...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
572634ec-c8ad-5b4d-929b-70cb99b84865
DOI
10.1101/2025.06.14.659649
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilitiesDOI 10.1101/2025.06.14.659649
Select a neighboring publication to make it the new centre.